Form D · Biotechnology

iontherapeutics, Inc.

Los Angeles, CA · CIK 0001464726

Offering snapshot reported Jun 17, 2009 · SEC filing

Reported sold
$110K
Offering amount: $2M
Investors reported
4
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
May 3, 2009
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$55K$110KMay 22, 2009: $85,000.00May 22, 2009Jun 17, 2009: $110,000.00Jun 17, 2009

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$85,000 → $110,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 17, 2009Amendment$110,000$25,000vs May 22, 20094SEC filing
May 22, 2009Initial$85,000No comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-131437

Source: Form D, filed Jun 17, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Gary Brown Director
Victoria Reade Roizman Director, Executive
Keith Roizman Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
8576 Cole Crest Drive
Los Angeles, CA, 90046